Bristol-Myers Squibb Net Slumps Bristol-Myers Squibb (BMY:NYSE - news - research) reported a sharply lower profit in the third-quarter as generic competition continued to eat away at drug sales and the company ratcheted up spending on research and development of new drugs. 
Is this a piece of news regarding world politics, sports, business, or science and technology? 